CHTRX
Price
$21.34
Change
+$0.21 (+0.99%)
Updated
Jul 3 closing price
Net Assets
3.59B
VITSX
Price
$150.04
Change
+$1.28 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

CHTRX vs VITSX

Header iconCHTRX vs VITSX Comparison
Open Charts CHTRX vs VITSXBanner chart's image
Invesco Charter A
Price$21.34
Change+$0.21 (+0.99%)
VolumeN/A
Net Assets3.59B
Vanguard Total Stock Market Idx I
Price$150.04
Change+$1.28 (+0.86%)
VolumeN/A
Net Assets1.82T
CHTRX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CHTRX vs. VITSX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHTRX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. CHTRX (3.59B). VITSX pays higher dividends than CHTRX: VITSX (1.22) vs CHTRX (0.47). CHTRX was incepted earlier than VITSX: CHTRX (57 years) vs VITSX (28 years). CHTRX (1.01) is less costly to investors than VITSX (0.03). CHTRX is a more actively managed with annual turnover of: 37.00 vs. VITSX (2.00). CHTRX has a lower initial minimum investment than VITSX: CHTRX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 13.90 vs. CHTRX (8.31). VITSX return over 5 years is better than : 95.64 vs. CHTRX (44.13).
CHTRXVITSXCHTRX / VITSX
Total Expense Ratio1.010.033,367%
Annual Report Gross Expense Ratio1.010.033,367%
Fund Existence57 years28 years-
Gain YTD7.9966.423124%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.59B1.82T0%
Annual Yield % from dividends0.471.2239%
Returns for 1 year8.3113.9060%
Returns for 3 years42.2162.1268%
Returns for 5 years44.1395.6446%
Returns for 10 years6.23198.643%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.750.07
+10.12%
Trinity Biotech plc
CATX3.680.29
+8.55%
Perspective Therapeutics
CGEN1.760.02
+1.15%
Compugen Ltd
GIB106.190.93
+0.88%
CGI
PSMT106.610.06
+0.06%
PriceSmart